| Literature DB >> 31172697 |
Kyung Bok Lee1, Jung Gon Lee2, Beom Joon Kim2, Jun Yup Kim2, Keon Joo Lee2, Moon Ku Han2, Jong Moo Park3, Kyusik Kang3, Yong Jin Cho4, Hong Kyun Park4, Keun Sik Hong4, Tai Hwan Park5, Soo Joo Lee6, Mi Sun Oh7, Kyung Ho Yu7, Byung Chul Lee7, Jae Kwan Cha8, Dae Hyun Kim8, Joon Tae Kim9, Jun Lee10, Jeong Ho Hong11, Sung Il Sohn11, Dong Eog Kim12, Jay Chol Choi13, Min Ju Yeo14, Wook Joo Kim15, Jae Eun Chae16, Ji Sung Lee17, Juneyoung Lee16, Hee Joon Bae18.
Abstract
BACKGROUND: Patients who survive an acute phase of stroke are at risk of falls and fractures afterwards. However, it is largely unknown how frequent fractures occur in the Asian stroke population.Entities:
Keywords: Fracture; Incidence; Stroke
Mesh:
Year: 2019 PMID: 31172697 PMCID: PMC6556443 DOI: 10.3346/jkms.2019.34.e164
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
The cumulative incidence functions of each type of fracture for 4 years after acute ischemic stroke
| Fracture type | No. of event | 95% confidence interval | |||
|---|---|---|---|---|---|
| % at 6 mon | % at 1 yr | % at 2 yr | % at 4 yr | ||
| Any fracture | 1,616 | 2.63 (2.35–2.93) | 4.43 (4.07–4.82) | 8.09 (7.60–8.60) | 13.00 (12.38–13.64) |
| Spine fracture | 712 | 1.11 (0.93–1.31) | 1.88 (1.64–2.14) | 3.28 (2.97–3.62) | 5.79 (5.37–6.24) |
| Hip fracture | 397 | 0.61 (0.48–0.77) | 1.03 (0.86–1.23) | 1.86 (1.63–2.12) | 3.15 (2.84–3.49) |
| Other fracture | 714 | 1.03 (0.86–1.23) | 1.81 (1.57–2.06) | 3.51 (3.18–3.85) | 5.61 (5.20–6.05) |
Comparison of the cumulative incidence functions between spine and hip fractures
| Variables | Any fracture | Spine fracture | Hip fracture | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % at 6 mon | % at 1 yr | % at 2 yr | % at 4 yr | % at 6 mon | % at 1 yr | % at 2 yr | % at 4 yr | % at 6 mon | % at 1 yr | % at 2 yr | % at 4 yr | ||
| Age, yr | |||||||||||||
| < 55 | 0.66 | 1.62 | 2.88 | 5.79 | 0.10 | 0.25 | 0.40 | 0.97 | 0.00 | 0.00 | 0.10 | 0.41 | |
| 55–64 | 1.42 | 2.75 | 5.45 | 9.19 | 0.49 | 0.89 | 1.51 | 2.98 | 0.13 | 0.40 | 0.75 | 1.30 | |
| 65–74 | 2.47 | 4.35 | 8.72 | 14.73 | 1.00 | 1.86 | 3.83 | 7.16 | 0.48 | 0.94 | 1.77 | 3.14 | |
| 75–84 | 4.02 | 6.59 | 11.61 | 17.71 | 1.90 | 3.21 | 5.28 | 9.09 | 0.96 | 1.59 | 3.11 | 5.43 | |
| ≥ 85 | 6.69 | 8.74 | 12.70 | 16.38 | 3.04 | 4.01 | 5.80 | 7.41 | 2.91 | 3.88 | 5.40 | 7.01 | |
| Men | 1.53 | 2.64 | 5.23 | 8.47 | 0.52 | 0.87 | 1.82 | 3.07 | 0.32 | 0.58 | 1.12 | 1.87 | |
| < 55 | 0.75 | 1.71 | 2.94 | 5.60 | 0.07 | 0.14 | 0.27 | 0.78 | 0.00 | 0.00 | 0.14 | 0.31 | |
| 55–64 | 1.04 | 2.03 | 4.05 | 7.03 | 0.55 | 0.86 | 1.35 | 2.13 | 0.18 | 0.43 | 0.74 | 1.16 | |
| 65–74 | 1.50 | 2.80 | 6.04 | 9.74 | 0.29 | 0.78 | 2.23 | 4.12 | 0.34 | 0.73 | 1.40 | 2.21 | |
| 75–84 | 2.69 | 3.85 | 7.33 | 10.87 | 0.95 | 1.46 | 2.86 | 4.56 | 0.66 | 1.02 | 1.97 | 3.49 | |
| ≥ 85 | 3.19 | 3.98 | 7.97 | 10.82 | 2.01 | 2.81 | 4.82 | 5.62 | 1.20 | 1.20 | 2.39 | 4.02 | |
| Women | 4.21 | 7.02 | 12.20 | 19.51 | 1.99 | 3.33 | 5.40 | 9.73 | 1.02 | 1.68 | 2.93 | 5.00 | |
| < 55 | 0.39 | 1.35 | 2.71 | 6.29 | 0.19 | 0.58 | 0.77 | 1.48 | 0.00 | 0.00 | 0.00 | 0.68 | |
| 55–64 | 2.39 | 4.62 | 9.08 | 14.78 | 0.32 | 0.96 | 1.91 | 5.17 | 0.00 | 0.32 | 0.80 | 1.67 | |
| 65–74 | 3.87 | 6.56 | 12.57 | 21.89 | 2.02 | 3.41 | 6.13 | 11.54 | 0.69 | 1.25 | 2.29 | 4.47 | |
| 75–84 | 5.13 | 8.88 | 15.16 | 23.39 | 2.70 | 4.67 | 7.31 | 12.90 | 1.21 | 2.06 | 4.06 | 7.05 | |
| ≥ 85 | 8.52 | 11.23 | 15.18 | 19.30 | 3.58 | 4.63 | 6.32 | 8.36 | 3.82 | 5.31 | 7.01 | 8.61 | |
| Disability, mRS | |||||||||||||
| 0–1 | 1.92 | 3.74 | 7.53 | 12.24 | 0.84 | 1.76 | 3.20 | 5.69 | 0.24 | 0.45 | 0.98 | 2.02 | |
| 2–3 | 2.81 | 4.64 | 8.44 | 14.41 | 1.27 | 2.05 | 3.80 | 7.04 | 0.57 | 1.07 | 2.02 | 3.57 | |
| 4–5 | 3.55 | 5.29 | 8.52 | 12.28 | 1.33 | 1.83 | 2.69 | 4.18 | 1.29 | 1.93 | 3.11 | 4.47 | |
| Osteoporosis | |||||||||||||
| No | 1.35 | 2.46 | 5.05 | 8.45 | 0.38 | 0.67 | 1.55 | 2.98 | 0.31 | 0.53 | 1.05 | 1.79 | |
| Yes | 4.71 | 7.65 | 13.01 | 20.39 | 2.31 | 3.85 | 6.13 | 10.40 | 1.10 | 1.83 | 3.18 | 5.38 | |
| eGFR, mL/min/1.73 m2 | |||||||||||||
| ≥ 60 | 2.32 | 4.12 | 7.73 | 12.60 | 1.00 | 1.76 | 3.15 | 5.61 | 0.49 | 0.89 | 1.65 | 2.79 | |
| < 60 | 3.88 | 5.71 | 9.54 | 14.59 | 1.54 | 2.33 | 3.83 | 6.54 | 1.10 | 1.58 | 2.72 | 4.61 | |
mRS = modified Rankin Scale, eGFR = estimated glomerular filtration rates.
Fig. 1CIF estimates of any fracture for each subgroup. (A) Age over 10-year interval, (B) gender, (C) disability at discharge, and (D) osteoporosis.
CIF = cumulative incidence function.
Predictors of any fracture at 4 years after acute ischemic stroke
| Variables | CIF at 4 years, % (95% CI) | Adjusted HR (95% CI) | |||
|---|---|---|---|---|---|
| Age, per 10 yr | < 0.001 | 1.23 (1.17–1.30) | < 0.001 | ||
| < 55 | 5.79 (4.79–6.92) | ||||
| 55–64 | 9.19 (8.02–10.45) | ||||
| 65–74 | 14.73 (13.57–15.95) | ||||
| 75–84 | 17.71 (16.35–19.12) | ||||
| ≥ 85 | 16.38 (13.77–19.19) | ||||
| Gender | < 0.001 | ||||
| Men | 8.47 (7.81–9.16) | 1.00 | |||
| Women | 19.51 (18.37–20.67) | 1.74 (1.54–1.97) | < 0.001 | ||
| Body mass index | < 0.022 | ||||
| < 18.5 | 14.72 (11.92–17.79) | 0.96 (0.77–1.20) | 0.696 | ||
| 18.5–22.9 | 13.90 (12.87–14.96) | 1.00 | |||
| 23–24.9 | 12.49 (11.34–13.69) | 1.03 (0.91–1.17) | 0.625 | ||
| ≥ 25 | 12.05 (10.96–13.19) | 1.02 (0.90–1.15) | 0.791 | ||
| Previous stroke | 15.34 (13.78–16.98) | < 0.001 | 1.11 (0.98–1.27) | 0.105 | |
| Previous fracture | < 0.001 | ||||
| No | 10.52 (9.89–11.17) | 1.00 | |||
| Yes | 22.87 (21.15–24.63) | 1.72 (1.54–1.92) | < 0.001 | ||
| Osteoporosis | < 0.001 | ||||
| No | 8.45 (7.81–9.12) | 1.00 | |||
| Yes | 20.39 (19.19–21.62) | 1.44 (1.27–1.63) | < 0.001 | ||
| Hypertension | 13.77 (13.00–14.56) | < 0.001 | 0.98 (0.87–1.10) | 0.703 | |
| Diabetes | 12.14 (11.10–13.22) | 0.079 | 0.88 (0.79–0.98) | 0.023 | |
| Hyperlipidemia | 13.58 (12.49–14.72) | 0.198 | 1.06 (0.96–1.18) | 0.242 | |
| Atrial fibrillation | 12.22 (10.90–13.61) | 0.013 | 0.73 (0.63–0.83) | < 0.001 | |
| Current smoking | 8.42 (7.45–9.46) | < 0.001 | 0.99 (0.86–1.15) | 0.939 | |
| Dementia | 16.39 (14.90–17.95) | < 0.001 | 1.03 (0.91–1.16) | 0.689 | |
| Parkinsonism | 15.48 (12.26–19.06) | 0.157 | 0.82 (0.64–1.06) | 0.127 | |
| eGFR | 0.067 | ||||
| ≥ 90 | 12.27 (11.30–13.27) | 1.00 | |||
| 60–89 | 12.94 (11.98–13.92) | 0.96 (0.85–1.07) | 0.427 | ||
| 30–59 | 14.66 (13.10–16.29) | 0.93 (0.80–1.08) | 0.336 | ||
| 15–29 | 11.09 (7.02–16.19) | 0.77 (0.50–1.19) | 0.244 | ||
| < 15 | 17.83 (12.28–24.23) | 1.27 (0.85–1.90) | 0.245 | ||
| Discharge antithrombotic | 9.29 (7.38–11.45) | < 0.001 | 0.72 (0.57–0.90) | 0.005 | |
| Discharge destination | 12.98 (11.91–14.11) | 0.528 | 0.99 (0.87–1.12) | 0.843 | |
| Disability at discharge | 0.006 | ||||
| Independent | 12.24 (11.31–13.22) | 1.00 | |||
| Mild to moderate | 14.41 (13.32–15.54) | 1.02 (0.90–1.14) | 0.798 | ||
| Severe | 12.28 (11.08–13.55) | 0.74 (0.62–0.87) | < 0.001 | ||
CIF = cumulative incidence function, CI = confidence interval, HR = hazard ratio, eGFR = estimated glomerular filtration rates.
aP value by Gray's test for competing risk data; bP value by Fine and Gray model for competing risk data.